Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2024
Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067Maganizo B Chagomerana, Carlee B Moser, Minhee Kang, et al.The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|June 11, 2026
Low awareness of HIV status and high proportion of recent infections among young travestis and trans women in BrazilEmilia M Jalil, Carolina Coutinho, Thaylla Wargas, et al.International Journal of Environmental Research and Public Health|February 15, 2022
High Rates of Sexualized Drug Use or Chemsex among Brazilian Transgender Women and Young Sexual and Gender MinoritiesEmilia M Jalil, Thiago S Torres, Claudia C de A Pereira, et al.Journal of the International AIDS Society|March 7, 2022
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas studyEmilia M Jalil, Thiago S Torres, Paula M Luz, et al.Journal of the International AIDS Society|October 13, 2022
Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP studyKelika A Konda, Thiago S Torres, Gabriela Mariño, et al.AIDS (London, England)|June 9, 2026
Characterization of HIV acquisitions during a large oral PrEP implementation study: insights from the ImPrEP studyBrenda Hoagland, Thiago Silva Torres, Carolina Coutinho, et al.Vaccine|August 6, 2024
Anti-PF4 positivity and platelet activation after Ad26.COV2·S vaccination in BrazilJoanna Bokel, Remy Martins-Gonçalves, Eduarda Grinsztejn, et al.Journal of the International AIDS Society|July 2, 2025
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB-Brasil studyCristina Pimenta, Claudio G Mann, Brenda Hoagland, et al.Lancet (London, England)|March 9, 2020
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trialSusan E Krown, Carlee B Moser, Patrick MacPhail, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2018
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical TrialMina C Hosseinipour, Minhee Kang, Susan E Krown, et al.Pageof 10